Sep 2026
CD20 targeted nanomedicine enhances anti-tumor immunity in diffuse large B-cell lymphoma by activating cGAS/STING pathway.
It is found that PLK4 was up-regulated in DLBCL, and its silencing significantly inhibited tumor growth, and the combination of si-PLK4 and VCR exerted stronger anti-tumor effects than either treatment alone, which was mediated by activating cGAS-STING pathway.
Zuofei Chi, Nan-Nan Xu, Ying Sun et al.
· Cancer Letters · 0 citations